How the COVID-19 Vaccines for Kids Differ From the Adult Shot

Published on September 22, 2021

Pfizer announced Monday that its COVID-19 vaccine for children ages 5 to 11 elicited a robust and safe response in clinical trials. The pharmaceutical company said it would seek emergency use authorization (EUA) for the vaccine from the Food and Drug Administration. The EUA…

Read Full Article (External Site)